» Articles » PMID: 37325705

Method for Determining Predictor Factor for Worse Outcomes in Kidney Transplant Recipients Infected with Coronavirus Disease 2019 in a Systematic Review and Meta-analysis Research

Abstract

The systematic review and meta-analysis were conducted for COVID-19 infections in kidney transplant patients. Recent research on this topic was still scarce and limited meta-analysis research discussion, specific to some risks or treatment in kidney transplantation patients with COVID-19 infection. Therefore, this article demonstrated the fundamental steps to conducting systematic review and meta-analysis studies to derive a pooled estimate of predictor factors of worse outcomes in kidney transplant patients with positive for the SARS-CoV- 2 test•PICOT Framework to determine the research scope•PRISMA strategy for study selection•Forest Plot for meta-analysis study.

References
1.
Crespo M, Mazuecos A, Rodrigo E, Gavela E, Villanego F, Sanchez-Alvarez E . Respiratory and Gastrointestinal COVID-19 Phenotypes in Kidney Transplant Recipients. Transplantation. 2020; 104(11):2225-2233. DOI: 10.1097/TP.0000000000003413. View

2.
Ghaffari Rahbar M, Nafar M, Khoshdel A, Dalili N, Abrishami A, Firouzan A . Low rate of COVID-19 pneumonia in kidney transplant recipients-A battle between infection and immune response?. Transpl Infect Dis. 2020; 22(5):e13406. PMC: 7404525. DOI: 10.1111/tid.13406. View

3.
Benotmane I, Perrin P, Vargas G, Bassand X, Keller N, Lavaux T . Biomarkers of Cytokine Release Syndrome Predict Disease Severity and Mortality From COVID-19 in Kidney Transplant Recipients. Transplantation. 2020; 105(1):158-169. DOI: 10.1097/TP.0000000000003480. View

4.
Benotmane I, Gautier-Vargas G, Wendling M, Perrin P, Velay A, Bassand X . In-depth virological assessment of kidney transplant recipients with COVID-19. Am J Transplant. 2020; 20(11):3162-3172. PMC: 7436721. DOI: 10.1111/ajt.16251. View

5.
Perez-Saez M, Blasco M, Redondo-Pachon D, Ventura-Aguiar P, Bada-Bosch T, Perez-Flores I . Use of tocilizumab in kidney transplant recipients with COVID-19. Am J Transplant. 2020; 20(11):3182-3190. PMC: 7405397. DOI: 10.1111/ajt.16192. View